S. Drube

发表

Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells

M. Grez, T. Heinzel, O. Krämer, 2014, British Journal of Cancer.

In various tumour cell lines the peptide bradykinin B2 receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist

C. Liebmann, S. Drube, 2000, British journal of pharmacology.

The p38-MK2/3 Module Is Critical for IL-33–Induced Signaling and Cytokine Production in Dendritic Cells

M. Gaestel, T. Kamradt, T. Yakovleva, 2018, The Journal of Immunology.

PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome

C. Stadelmann, Sylvia Heink, R. Wetzker, 2011, European journal of immunology.

Tim-3 is dispensable for allergic inflammation and respiratory tolerance in experimental asthma

G. Hansen, T. Kamradt, A. Meyer‐Bahlburg, 2021, PloS one.

Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells.

W. Sippl, M. Christmann, S. Mahboobi, 2021, Cell chemical biology.

Determination of the number of RAD51 molecules in different human cell lines

H. Nasheuer, C. Biskup, C. Melle, 2019, Cell cycle.

TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases

F. Greten, T. Kamradt, O. Krämer, 2015, Oncotarget.

The Heat Shock Protein 90 (HSP90) Is Required for the IL-33-Induced Cytokine Production in Mast Cells (MCs)

U. Jäger, I. Peters, S. Drube, 2022, International journal of molecular sciences.

The Neurobeachin-like 2 Protein Regulates Mast Cell Homeostasis

B. Nieswandt, T. Kamradt, D. Stegner, 2017, The Journal of Immunology.

This information is current as Mast Cell Homeostasis The Neurobeachin-like 2 Protein Regulates

B. Nieswandt, T. Kamradt, D. Stegner, 2017 .

MK2/3 Are Pivotal for IL-33–Induced and Mast Cell–Dependent Leukocyte Recruitment and the Resulting Skin Inflammation

M. Gaestel, T. Kamradt, I. Irmler, 2016, The Journal of Immunology.

Subthreshold IKK activation modulates the effector functions of primary mast cells and allows specific targeting of transformed mast cells

F. Greten, B. Nieswandt, T. Herdegen, 2015, Oncotarget.

Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia

Matthew J. Craig, K. Pienta, T. Suda, 2011 .

Epidermal Growth Factor Receptor Expression Licenses Type-2 Helper T Cells to Function in a T Cell Receptor-Independent Fashion

R. Maizels, M. Mokry, P. Coffer, 2017, Immunity.

Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit.

Werner Müller, T. Krieg, C. Wickenhauser, 2011, Blood.

A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - Implications for Long COVID?

C. Zielinski, A. Stallmach, M. Pletz, 2022, medRxiv.

A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients – indications for their potential involvement in the development of Long COVID?

C. Puta, S. Baumgart, C. Zielinski, 2022, Frontiers in Immunology.

IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt+ Treg generation via enhanced IL‐6 induction

M. Gaestel, T. Kamradt, A. Hutloff, 2021, Immunology.

IL‐33‐activated murine mast cells control the dichotomy between RORγt+ and Helios+ Tregs via the MK2/3‐mediated IL‐6 production in vitro

M. Gaestel, T. Kamradt, Isabel Meininger, 2019, European journal of immunology.

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells

K. Halfter, A. Hochhaus, C. Sorio, 2018, Oncotarget.

Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling.

C. Valkova, C. Liebmann, S. Drube, 2006, Cellular signalling.

Muscarinic M2 receptors mediate transactivation of EGF receptor through Fyn kinase and without matrix metalloproteases.

C. Valkova, C. Liebmann, S. Drube, 2006, Cellular signalling.

Membrane‐bound stem cell factor is the major but not only driver of fibroblast‐induced murine skin mast cell differentiation

M. Maurer, M. Metz, A. Dudeck, 2017, Experimental dermatology.

The IL-33-induced p38-/JNK1/2-TNFα axis is antagonized by activation of β-adrenergic-receptors in dendritic cells

M. Gaestel, T. Herdegen, T. Kamradt, 2020, Scientific Reports.

Intra-abdominal Complications in Peritoneal Dialysis with Special Reference to Peritoneal Fibrosis

B. Hermanns, H. Schmitt, H. Sieberth, 1997 .

The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.

Thomas Kamradt, Sylvia Heink, J. Norgauer, 2010, Blood.

Activated EGF receptor may balance ERK-inhibitory network signalling pathways.

C. Valkova, C. Liebmann, S. Drube, 2006, Cellular signalling.

Interleukin‐3 stabilizes CD124/IL‐4α surface expression in mast cells via Tyk2 and STAT6

U. Jäger, N. Andreas, Birgit Strotmann, 2022, Immunology.

ATP/IL‐33‐triggered hyperactivation of mast cells results in an amplified production of pro‐inflammatory cytokines and eicosanoids

O. Werz, M. Groth, E. Serfling, 2021, Immunology.

mast cells The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in

Sylvia Heink, J. Norgauer, T. Kamradt, 2011 .

Mast cells initiate the vascular response to contact allergens by sensing cell stress.

A. Dudeck, Jan Dudeck, S. Drube, 2020, The Journal of allergy and clinical immunology.

Acute resistance exercise-induced changes in IL-6, IL-10, and IL-1ra in healthy adults: a systematic review and meta-analysis.

C. Puta, W. Bloch, P. Reuken, 2023, medRxiv.

A complicated liaison: IL-33 and IL-33R in arthritis pathogenesis

T. Kamradt, S. Drube, 2013, Arthritis Research & Therapy.

C-Kit controls IL-1β-induced effector functions in HMC-cells.

T. Kamradt, S. Drube, C. Göpfert, 2012, European journal of pharmacology.